company background image

Themis Medicare NSEI:THEMISMED Stock Report

Last Price


Market Cap







28 Jun, 2022


Company Financials
THEMISMED fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance6/6
Financial Health6/6

THEMISMED Stock Overview

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.

Themis Medicare Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Themis Medicare
Historical stock prices
Current Share Price₹748.40
52 Week High₹1,197.00
52 Week Low₹656.65
1 Month Change-6.50%
3 Month Change-21.20%
1 Year Change6.90%
3 Year Change265.43%
5 Year Change42.11%
Change since IPO483.32%

Recent News & Updates

May 27
Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's

Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's

Themis Medicare Limited ( NSE:THEMISMED ) has announced that it will be increasing its dividend on the 19th of October...

May 12
Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?

Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...

Shareholder Returns

THEMISMEDIN PharmaceuticalsIN Market

Return vs Industry: THEMISMED exceeded the Indian Pharmaceuticals industry which returned -15.9% over the past year.

Return vs Market: THEMISMED exceeded the Indian Market which returned -0% over the past year.

Price Volatility

Is THEMISMED's price volatile compared to industry and market?
THEMISMED volatility
THEMISMED Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement6.9%
10% most volatile stocks in IN Market9.9%
10% least volatile stocks in IN Market4.5%

Stable Share Price: THEMISMED is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: THEMISMED's weekly volatility (6%) has been stable over the past year.

About the Company

1969976Sachin Patel

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001.

Themis Medicare Fundamentals Summary

How do Themis Medicare's earnings and revenue compare to its market cap?
THEMISMED fundamental statistics
Market Cap₹6.70b
Earnings (TTM)₹728.81m
Revenue (TTM)₹3.95b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
THEMISMED income statement (TTM)
Cost of Revenue₹1.48b
Gross Profit₹2.46b
Other Expenses₹1.74b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date


Earnings per share (EPS)79.22
Gross Margin62.46%
Net Profit Margin18.47%
Debt/Equity Ratio27.3%

How did THEMISMED perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio

Does THEMISMED pay a reliable dividends?

See THEMISMED dividend history and benchmarks
When do you need to buy THEMISMED by to receive an upcoming dividend?
Themis Medicare dividend dates
Ex Dividend DateSep 08 2022
Dividend Pay DateOct 19 2022
Days until Ex dividend71 days
Days until Dividend pay date112 days

Does THEMISMED pay a reliable dividends?

See THEMISMED dividend history and benchmarks
We’ve recently updated our valuation analysis.


Is THEMISMED undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for THEMISMED?

Other financial metrics that can be useful for relative valuation.

THEMISMED key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.8x
Enterprise Value/EBITDA7.6x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does THEMISMED's PE Ratio compare to its peers?

THEMISMED PE Ratio vs Peers
The above table shows the PE ratio for THEMISMED vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average13.8x
506879 Gujarat Themis Biosyn
539872 Bajaj HealthCare
SIGACHI Sigachi Industries
532815 SMS Pharmaceuticals
THEMISMED Themis Medicare

Price-To-Earnings vs Peers: THEMISMED is good value based on its Price-To-Earnings Ratio (9.5x) compared to the peer average (13.8x).

Price to Earnings Ratio vs Industry

How does THEMISMED's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

Price-To-Earnings vs Industry: THEMISMED is good value based on its Price-To-Earnings Ratio (9.5x) compared to the Indian Pharmaceuticals industry average (20.9x)

Price to Earnings Ratio vs Fair Ratio

What is THEMISMED's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

THEMISMED PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio9.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate THEMISMED's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of THEMISMED when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: THEMISMED (₹748.4) is trading above our estimate of fair value (₹97.21)

Significantly Below Fair Value: THEMISMED is trading above our estimate of fair value.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate THEMISMED's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is Themis Medicare forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Themis Medicare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Past Performance

How has Themis Medicare performed over the past 5 years?

Past Performance Score


Past Performance Score 6/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: THEMISMED has high quality earnings.

Growing Profit Margin: THEMISMED's current net profit margins (18.5%) are higher than last year (15.5%).

Past Earnings Growth Analysis

Earnings Trend: THEMISMED's earnings have grown significantly by 47.7% per year over the past 5 years.

Accelerating Growth: THEMISMED's earnings growth over the past year (104.1%) exceeds its 5-year average (47.7% per year).

Earnings vs Industry: THEMISMED earnings growth over the past year (104.1%) exceeded the Pharmaceuticals industry 9%.

Return on Equity

High ROE: THEMISMED's Return on Equity (25.4%) is considered high.

Discover strong past performing companies

Financial Health

How is Themis Medicare's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: THEMISMED's short term assets (₹2.1B) exceed its short term liabilities (₹1.1B).

Long Term Liabilities: THEMISMED's short term assets (₹2.1B) exceed its long term liabilities (₹307.7M).

Debt to Equity History and Analysis

Debt Level: THEMISMED's net debt to equity ratio (18.1%) is considered satisfactory.

Reducing Debt: THEMISMED's debt to equity ratio has reduced from 54.2% to 27.3% over the past 5 years.

Debt Coverage: THEMISMED's debt is well covered by operating cash flow (43.8%).

Interest Coverage: THEMISMED's interest payments on its debt are well covered by EBIT (9.8x coverage).

Balance Sheet

Discover healthy companies


What is Themis Medicare current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 2/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


Current Dividend Yield

Upcoming Dividend Payment

TodayJun 28 2022Ex Dividend DateSep 08 2022Dividend Pay DateOct 19 202241 days from Ex DividendBuy in the next 71 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: THEMISMED's dividend (0.67%) is higher than the bottom 25% of dividend payers in the Indian market (0.42%).

High Dividend: THEMISMED's dividend (0.67%) is low compared to the top 25% of dividend payers in the Indian market (1.87%).

Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, THEMISMED has been paying a dividend for less than 10 years.

Growing Dividend: THEMISMED's dividend payments have increased, but the company has only paid a dividend for 2 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (6.3%), THEMISMED's dividend payments are thoroughly covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (33.4%), THEMISMED's dividend payments are well covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Sachin Patel (46 yo)





Dr. Sachin Dinesh Patel, Ph D., CChem. has been Chief Executive Officer and Managing Director of Themis Medicare Limited since February 14, 2017.He served as Deputy Managing Director at Themis Medicare Lt...

CEO Compensation Analysis

Compensation vs Market: Sachin's total compensation ($USD85.47K) is above average for companies of similar size in the Indian market ($USD38.33K).

Compensation vs Earnings: Sachin's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: THEMISMED's management team is seasoned and experienced (5.3 years average tenure).

Board Members

Experienced Board: THEMISMED's board of directors are considered experienced (8.3 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Themis Medicare Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Themis Medicare Limited
  • Ticker: THEMISMED
  • Exchange: NSEI
  • Founded: 1969
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: ₹6.702b
  • Shares outstanding: 9.20m
  • Website:

Number of Employees


  • Themis Medicare Limited
  • 11/12 Udyog Nagar Industrial Estate
  • S. V. Road
  • Mumbai
  • Maharashtra
  • 400104
  • India


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/28 00:00
End of Day Share Price2022/06/28 00:00
Annual Earnings2022/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.